Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLong-Term Deferred TaxNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecuritiesSecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhinebeck Bancorp (RBKB) Cash & Equivalents: 2017-2025

Historic Cash & Equivalents for Rhinebeck Bancorp (RBKB) over the last 3 years, with Sep 2025 value amounting to $103.5 million.

  • Rhinebeck Bancorp's Cash & Equivalents rose 123.08% to $103.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $103.5 million, marking a year-over-year increase of 123.08%. This contributed to the annual value of $37.5 million for FY2024, which is 69.39% up from last year.
  • Per Rhinebeck Bancorp's latest filing, its Cash & Equivalents stood at $103.5 million for Q3 2025, which was up 15.45% from $89.6 million recorded in Q2 2025.
  • In the past 5 years, Rhinebeck Bancorp's Cash & Equivalents ranged from a high of $103.5 million in Q3 2025 and a low of $22.1 million during Q4 2023.
  • In the last 3 years, Rhinebeck Bancorp's Cash & Equivalents had a median value of $37.5 million in 2024 and averaged $48.3 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first tumbled by 56.47% in 2022, then soared by 160.24% in 2025.
  • Rhinebeck Bancorp's Cash & Equivalents (Quarterly) stood at $72.1 million in 2021, then crashed by 56.47% to $31.4 million in 2022, then declined by 29.49% to $22.1 million in 2023, then soared by 69.39% to $37.5 million in 2024, then spiked by 123.08% to $103.5 million in 2025.
  • Its Cash & Equivalents was $103.5 million in Q3 2025, compared to $89.6 million in Q2 2025 and $50.5 million in Q1 2025.